Original Research
Published on 24 May 2017
AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term Effects
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2017.00292
- 7,157 views
- 30 citations
